Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
European Journal of Heart Failure
|
September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
Kalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
Cardiovascular Research
|
July 24, 2020
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study
Kenneth Mangion, Andrew Morrow, Catherine Bagot, et al.
European Journal of Heart Failure
|
May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF
James P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
European Heart Journal
|
December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
European Journal of Heart Failure
|
February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial
Ninian N Lang, Faheem A Ahmad, John G Cleland, et al.
Lancet (London, England)
|
November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R Kalra, John G F Cleland, Mark C Petrie, et al.
JACC. Heart Failure
|
November 29, 2020
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study
G Michael Felker, John J V McMurray, John G Cleland, et al.
European Journal of Heart Failure
|
December 15, 2024
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI)
Jaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Circulation
|
September 25, 2023
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial
Peter A Henriksen, Peter Hall, Iain R MacPherson, et al.
JAMA Network Open
|
December 3, 2025
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial
Congying Xia, Amanda M Smith, Bénédicte Lefebvre, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
European Journal of Heart Failure
|
September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
Kalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
Cardiovascular Research
|
July 24, 2020
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study
Kenneth Mangion, Andrew Morrow, Catherine Bagot, et al.
European Journal of Heart Failure
|
May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF
James P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
European Heart Journal
|
December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
European Journal of Heart Failure
|
February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial
Ninian N Lang, Faheem A Ahmad, John G Cleland, et al.
Lancet (London, England)
|
November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
Paul R Kalra, John G F Cleland, Mark C Petrie, et al.
JACC. Heart Failure
|
November 29, 2020
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study
G Michael Felker, John J V McMurray, John G Cleland, et al.
European Journal of Heart Failure
|
December 15, 2024
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI)
Jaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Circulation
|
September 25, 2023
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial
Peter A Henriksen, Peter Hall, Iain R MacPherson, et al.
JAMA Network Open
|
December 3, 2025
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial
Congying Xia, Amanda M Smith, Bénédicte Lefebvre, et al.
Page
of 9